Baird Medical Investment Holdings Ltd

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive medical technologies, proudly sponsored and participated in the 2024 Guangdong Thyroid Surgery Committee Annual Meeting in Guangdong, China. The forum, hosted by the Guangdong Provincial Hospital of Traditional Chinese Medicine, brought together experts to advance thyroid disease treatment.

Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting

NEW YORK , Dec. 16, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. The program provided hands-on experience with a cutting-edge treatment that offers patients faster recovery times and effective relief from thyroid nodules.

Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care

NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Baird Medical Group (NASDAQ: BDMD), a leader in minimally invasive medical technologies, recently convened its 2024 Annual Review and 2025 Planning Meeting at the Baird Capital Tower in Guangzhou, China. The two-day event brought together executives, production leaders, and regional managers to reflect on the company's achievements and plan for the year ahead.

Baird Medical Charts 2025 Strategic Vision Following Milestone Year

NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored and participated in the 2024 7th Thyroid Disease Standardized Diagnosis and Treatment Forum and Guangdong Pharmaceutical Society Thyroid Specialist Committee Annual Meeting, held in Guangzhou, China. This prestigious forum, hosted by the Guangdong Provincial People's Hospital and organized by leading medical and pharmaceutical associations in Guangdong, brought together top experts and healthcare professionals to advance standardized treatment protocols for thyroid diseases.

Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China

NEW YORK , Nov. 11, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in microwave ablation technology, proudly participated in the recent Massachusetts Society of Otolaryngology (MSO) event. This year's event centered on emerging trends in Otolaryngology, with a focus on the increasing shift toward office-based surgical procedures.

Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event

NEW YORK , Nov. 4, 2024 /PRNewswire/ -- Baird Medical (Nasdaq: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, proudly participated in the 2024 American Thyroid Association (ATA) Annual Meeting. This year's event marked a milestone for Baird Medical, as it attracted significant interest from physicians and researchers worldwide, including attendees from the U.S., Europe, and South America.

Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting

NEW YORK , Oct. 28, 2024 /PRNewswire/ -- From October 24-27, Baird Medical proudly invited and gathered leading experts from the U.S. and China to advance the field of thyroid care through a series of impactful events, solidifying its role in the global academic and clinical exchange. On October 25, Baird hosted the Sixth Global Thyroid Microwave Ablation Technology Exchange Conference.

Baird Medical Advances Global Academic Collaboration in Thyroid Health

NEW YORK , Oct. 24, 2024 /PRNewswire/ -- Baird Medical, (NASDAQ: BDMD) a global leader in minimally invasive microwave ablation (MWA) technology, successfully participated in the prestigious 2024 American College of Surgeons (ACS) Clinical Congress held at the renowned Moscone Center in San Francisco. This year's congress attracted over 10,000 attendees, including 7,000 surgeons from around the world, making it one of the largest surgical events globally.

Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress

NEW YORK , Oct. 14, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medical devices in China, which recently expanded into the U.S. market following its U.S. FDA 510(k) clearances, today announced its participation in the upcoming American Thyroid Association (ATA) Annual Meeting.

Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting

Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth Net income reached US$4.4 million, representing 85.8% year-over-year growth GUANGZHOU, China , Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the "First Half of 2024").

Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024

Company Rings Opening Bell to Celebrate Closure of Business Combination and Begins Journey as a Public Company; Shares trade under "BDMD" Ticker FORT MILL, S.C. , Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd.

Baird Medical Lists in the U.S. on the Nasdaq Exchange

GUANGZHOU, China , Oct. 8, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced that the Company will participate in the following investor conference.

Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference

News for Baird Medical Investment Holdings Ltd Stock (BDMD)